Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

SOFIA MERAJVER, MD

University of Michigan Comprehensive Cancer Center

Engineering cancer metastases platforms for precise medicine

Funda Meric-Bernstam, MD

The University of Texas MD Anderson Cancer Center

Presented By Jacquelyn Vranicar and Jacquelyn and Lindsay’s METAvivor Team in memory of Kelsey Granowski

Optimizing TROP2-targeted antibody-drug conjugate therapy in metastatic breast cancer

VIVEK MITTAL, PhD

Weill Medical College of Cornell University

Targeting Epigenetic Regulator PRC2 as a Therapy for Established Metastasis

Lluis Morey, PhD

Sylvester Comprehensive Cancer Center, University of Miami

Presented by The Pittsburgh Metsquerade in honor of members Amy Fletcher, Bindy Koontz, Roberta Thomas Szpara and Laura Williams

Dual targeting of an epigenetic machinery and a cellular receptor to block metastatic breast cancer

Stefania Morganti, MD

Dana-Farber Cancer Institute

Presented by the Philadelphia METAvivor Gala in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Tracking minimal residual disease via circulating tumor DNA in patients with HER2+ metastatic breast cancer and exceptional response to therapy

Rita Mukhtar, MD

University of California, San Francisco

Presented by Lake Tahoe Music for METAvivor in honor of Kelly Shanahan, memory of Barbara Carter | Tonyia’s Hope in memory of Tonyia Lucas

The PLUMB Study: a Prospective study of LobUlar Metastatic Breast cancer using serial circulating tumor DNA to measure disease response

ERIK NELSON, PhD

University of Illinois

Targeting an immune-suppressive cholesterol metabolite in the treatment metastatic breast cancer

JOSH NEMAN, PhD

University of Southern California

Chemotherapy and tau interplay permeabilize BBB and facilitate brain metastasis

Steffi Oesterreich, PhD

University of Pittsburgh

Presented by Facebook Fundraisers

Targeting mesothelial – tumor cell interaction to treat invasive lobular cancer metastases

Thordur Oskarsson

H. Lee Moffitt Cancer Center & Research Institute, Inc.

Presented by Pittsburgh Metsquerade in honor of those living with and lost to MBC including Sheila Frankowski and Carol Zuro

Targeting stress signaling to enhance immunotherapy against metastatic breast cancer

Madeline Oudin, BSc, MSc, PhD

Tufts University

Presented by METAribbon Challengers

Investigating how obesity-driven changes in the tumor microenvironment promote metastatic outgrowth and chemoresistance in metas

Diwakar Pattabiraman, PhD

Geisel School of Medicine at Dartmouth

Presented in memory of Dee Dee Miller by Play: CLE to Cure: MBC

Differentiation therapy for metastatic breast cancer